Cosmetic products containing Scheduled Poisons

Tue, 08/06/2010

 

PRESS RELEASE

 

CONSUMERS CAUTIONED AGAINST USING COSMETIC PRODUCTS CONTAINING SCHEDULED POISONS

 

 

The public is advised to avoid buying and using the following cosmetic products:

 

No

Name of Products

Notification Number

Scheduled Poison Detected

Notification Holder

Manufacturer

1

ZARA REJUVENATION CREAM

NOT04081873KE

Hydroquinone

MUM BIO COS MANUFACTURING SDN BHD

 

MUM BIO COS SDN BHD

 

2

BEAUTY LINE BEAUTITUDE MULTI-PURPOSE CREAM

NOT081201209K

Tretinoin

BEAUTY LINE SKIN CARE & COSMETIC SDN BHD

 

YAKIN INVEST CORPORATION SDN BHD

3

PIGMENTATION RECOVERY COMPLEX

NOT081200745K

Tretinoin

MYCREME SKINCARE PRODUCTS

 

SKY RESOURCES SDN BHD

 

The product notifications of the above cosmetics have been cancelled by the Senior Director of Pharmaceutical Services following the detection of scheduled poisons hydroquinone and/or tretinoin.

 

The usage of hydroquinone and tretinoin in cosmetic products is prohibited due to the   

possible side effects to consumers if it is used without medical supervision.

 

Tretinoin can cause redness to the skin, peeling, discomfort and skin becomes sensitive to sunlight.

 

Hydroquinone can cause redness to the skin, discomfort, changes in skin colour and hypersensitivity. Hydroquinone inhibits the pigmentation process (depigmentation). This process attenuates the ability of the skin to protect our body from harmful UV rays and excessive sunlight which can bring risk of skin cancer. Excessive depigmentation is dangerous for those living in the tropical region

 

Anyone who is in possession of this product is advised to immediately cease selling/distributing/using it. Sellers are reminded that possession of this product  is an offence under the Control Of Drugs and Cosmetics Regulations 1984. Any individual who commits an offence under these Regulations can be fined up to a maximum of RM25,000 or to imprisonment for a term not exceeding 3 years or both, and for a second or subsequent offence he shall be liable on conviction to a fine not exceeding RM50,000 or to imprisonment for a term not exceeding 5 years or to both. A company found guilty can be fined up to RM50,000 for the first offence and fined up to a maximum of RM100,000 for a subsequent offence.

 

 

EISAH BT A. RAHMAN

Senior Director of Pharmaceutical Services

Ministry of Health

 

12 Mei 2010